Wearable device, algorithm show early detection promise
June 22, 2022 -- A wearable tracking tool and machine learning algorithm could augment molecular testing for COVID-19 and other conditions and provide an early warning that an infection is on the way before symptoms begin, according to a new study. Read More
Blood grouping, typing market estimated at $945 million
June 17, 2022 -- In 2021, the world market for blood grouping and blood typing rebounded from a 3.2% decline in 2020 due to COVID-19 impacts, reaching an estimated $945 million in revenues, according to an upcoming issue of the In Vitro Diagnostics Business Outlook. Read More
WHO open to exploring lab as pathway to SARS-CoV-2 spread
June 10, 2022 -- A team commissioned by the World Health Organization (WHO) said on Thursday that there is a need for more information to study how COVID-19 spread to the human population. Read More
ASCO presentation highlights clinical utility of ctDNA testing
June 6, 2022 -- Circulating tumor DNA (ctDNA) has the potential to identify patients with stage II colon cancer who would benefit most from chemotherapy after surgery and separate them from those who could avoid the toxicities of chemotherapy, according to an international study. Read More
FDA warns about Illumina NGS cybersecurity vulnerability
June 2, 2022 -- The U.S. Food and Drug Administration (FDA) on Thursday informed laboratory personnel and healthcare providers about a cybersecurity vulnerability affecting software for the Illumina NextSeq 550Dx, MiSeqDx, NextSeq 500, NextSeq 550, MiSeq, iSeq, and MiniSeq next-generation sequencing (NGS) instruments. Read More
Why best-of-breed LIS vendors might yet survive EHR’s invasion
May 31, 2022 -- Electronic health record (EHR) vendors are increasingly cannibalizing clinical departmental IT administration, and best-of-breed laboratory information systems (BoB-LIS) are often viewed as the next departmental IT lamb. Is EHR-based LIS therefore a foregone conclusion? Imogen Fitt of Signify Research offers a perspective. Read More
COVID-19 testing offers chance for diabetes screening, too
May 27, 2022 -- COVID-19 testing can provide an opportunity to also screen for other diseases like diabetes in marginalized communities such as Latinx individuals, according to a study published May 26 in JAMA Network Open. Read More
Laboratories stand ready if needed for monkeypox threat
May 26, 2022 -- It remains to be seen whether the much-covered monkeypox scare will turn out to be a significant crisis, a moderate concern of the likes of Zika, or just a media story of exaggerated importance. Bruce Carlson of Kalorama Information offers a perspective. Read More
AACC lobbies against greater regulation of lab-developed tests
May 25, 2022 -- The American Association for Clinical Chemistry (AACC) is urging Congress to not include a bill to mandate greater regulatory oversight of laboratory-developed tests as part of its omnibus U.S. Food and Drug Administration (FDA) user fee legislation. Read More
Biomarker data improves CT lung cancer screening's bottom line
May 24, 2022 -- The cost-effectiveness of low-dose computed tomography (CT) for lung cancer screening is improved by adding a plasma-based biomarker into the clinical evaluation, according to a study published May 24 in JAMA Network Open. Read More